People · Operator
Named in public records as an officer, director or promoter · active 2015–2017 · Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Zeno Pharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $33.3M | $622.9M | 2015 |
| XRad Therapeutics, Inc. | — | Biotechnology | Pre-Seed | $499K | $27.5M | 2017 |
Anthony Y. Sun at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Anthony Y. Sun on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Cam Y. Gallagher | 1 | 1 |
| Michael Y. Kastan | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.